BioAmber Secures CAD$20 Million Loan for Sarnia Plant

MINNEAPOLIS, MN, June 23, 2014 /CNW Telbec/ - BioAmber Inc. (NYSE: BIOA), an 
industrial biotechnology company producing sustainable chemicals, today 
announced that its Canadian subsidiary BioAmber Sarnia Inc., a joint venture 
with Mitsui & Co., has secured a CAD$20 million commercial loan from a 
financial consortium led by Export Development Canada and including Farm 
Credit Canada and Comerica Bank. 
The CAD$20 million senior secured loan will bear interest at an initial rate 
of 8%, tied to an agreed-on floating rate calculation from disbursement.  The 
loan's principal will be reimbursed over a period of six and a half years, 
commencing three (3) months after the completion of the commissioning and 
start-up phase of the Sarnia plant. 
The drawdown on the loan is subject to customary conditions, including 
continued progress on the construction of the Sarnia plant.  The CAD$20 
million will be used to complete the ongoing construction of the Sarnia plant 
and fund its start up and commissioning. 
When completed in early 2015, the Sarnia plant will be the world's largest 
bio-based succinic acid production facility.  The plant will convert Canadian 
agricultural products into bio-based succinic acid, a value added building 
block chemical that is used in a wide variety of everyday products.  BioAmber 
projects that over 90% of the 30,000 MT annual capacity will be exported. 
About BioAmber  
BioAmber (NYSE:BIOA) is an industrial biotechnology company producing 
sustainable chemicals. Its proprietary technology platform combines industrial 
biotechnology and chemical catalysts to convert renewable feedstock into 
sustainable chemicals for use in a wide variety of everyday products including 
plastics, resins, food additives and personal care products. For more 
information visit 
About Export Development Canada 
EDC is Canada's trade finance agency, providing financing and insurance 
solutions locally and around the world to help Canadian companies of any size 
respond to international business opportunities. As a profitable Crown 
corporation that operates on commercial principles, EDC works together with 
private and public-sector financial institutions to create greater capacity 
for Canadian companies to engage in trade and investment. 
About Farm Credit Canada 
FCC is Canada's leading agriculture lender, with a healthy portfolio of more 
than $26 billion and 20 consecutive years of portfolio growth. FCC is strong 
and stable - committed to serving the industry through all cycles, and to 
being socially and environmentally responsible. FCC provides financing, 
insurance, software, learning programs and other business services to 
producers, agribusinesses and agri-food operations. Employees understand 
agriculture and are committed to the success of customers and the industry. 
With FCC in the market, producers benefit, agriculture benefits, rural Canada 
benefits and so do all Canadians. For more information, visit 
About Comerica Bank 
Comerica Bank's Technology and Life Sciences Division is one of the United 
States' leading technology banking practices, offering a wide range of 
financial services tailored to corporate customers, entrepreneurs and 
professionals. Veteran bankers provide credit and financial services and 
products to young, growing, professionally backed technology and life sciences 
companies, as well as their more mature counterparts. The Technology and Life 
Sciences Division serves all major U.S. technology centers from offices 
coast-to-coast and its headquarters in Palo Alto, California. Comerica Bank is 
a subsidiary of Comerica Incorporated (NYSE: CMA), a financial services 
company that is among the 25 largest U.S. banking companies. For more 
information, visit 
Forward-Looking Statements 
This press release contains forward-looking statements, including statements 
related to the completion of our planned facility and the disbursement of the 
loan. All statements other than statements of historical fact contained in 
this press release are forward-looking statements. These statements often 
include words such as "believe," "expect," "anticipate," "intend," "plan," 
"estimate," "seek," "will," "may" or similar expressions. Forward-looking 
statements are subject to a number of risks and uncertainties, many of which 
involve factors or circumstances that are beyond BioAmber's control. 
BioAmber's actual results could differ materially from those stated or implied 
in forward-looking statements due to a number of factors, including but not 
limited to, risks detailed in BioAmber's most recent registration statement on 
Form S-1 filed with the Securities and Exchange Commission, as well as other 
documents that may be filed by the Company from time to time with the 
Securities and Exchange Commission. In particular, the following factors, 
among others, could cause results to differ materially from those expressed or 
implied by such forward-looking statements: the Company's limited operating 
history, the inability of the Company to execute on its manufacturing 
expansion strategy, including the construction of our planned facility in 
Sarnia, Ontario, the inability of the Company to comply with milestone 
covenants contained in certain of its agreements, the Company's limited sales 
of bio-succinic acid to date, the Company's inability to obtain additional 
financing, the Company's inability to leverage its bio-succinic acid 
technology to develop and commercialize derivatives of bio-succinic acid and 
other bio-based building block chemicals, and a decrease in demand for 
bio-succinic acid, bio-based 1,4 BDO and other bio-succinic acid derivatives. 
Although we believe that the expectations reflected in the forward-looking 
statements are reasonable, we cannot guarantee that the events and 
circumstances reflected in the forward-looking statements will be achieved or 
occur and the timing of events and circumstances and actual results could 
differ materially from those projected in the forward-looking statements. 
Accordingly, you should not place undue reliance on these forward-looking 
statements. All such statements speak only as of the date made, and we 
undertake no obligation to update or revise publicly any forward-looking 
statements, whether as a result of new information, future events or otherwise.

SOURCE  BioAmber Inc. 
BioAmber Investor Contact, Michael Rice, LifeSci Advisors, 250 West 55th 
Street Suite 16B, New York, NY 10019, 646-597-6979, 
To view this news release in HTML formatting, please use the following URL: 
CO: BioAmber Inc.
ST: Quebec
-0- Jun/23/2014 11:30 GMT
Press spacebar to pause and continue. Press esc to stop.